SCHEMBL4368833

SCHEMBL4368833

CC(O)(I)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42
CASP3 P42574 1/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
TGM2 P21980 1/20 0.38
GLS O94925 1/20 0.38
CHRM2 P08172 1/20 0.38
ELANE P08246 1/20 0.38
DRD3 P35462 1/20 0.38
POLB P06746 1/20 0.38
PLIN1 O60240 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
PLIN5 Q00G26 1/20 0.38
ABHD5 Q8WTS1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944717 0.83 CASP3 (0.43) ALDH1A1CA12CA9CASP3MEN1
SCHEMBL10496308 0.79 CASP3 (0.41) ALDH1A1CA12CA9CASP3MEN1
SCHEMBL30472938 0.78 CASP3 (0.46) ALDH1A1CASP3MEN1NPC1RAB9A
SCHEMBL2156119 0.78 CASP3 (0.46) ALDH1A1CASP3MEN1NPC1RAB9A
SCHEMBL7286383 0.75 CASP3 (0.41) ALDH1A1CA12CA9CASP3TGM2
SCHEMBL5706500 0.75 CA12 (0.47) ALDH1A1CA12CA9CASP3MEN1
SCHEMBL28814233 0.75 ALDH1A1 (0.41) ALDH1A1CA12CA9CASP3MEN1
SCHEMBL28078141 0.75 ALDH1A1 (0.41) ALDH1A1CA12CA9CASP3MEN1
SCHEMBL19067757 0.74 CASP3 (0.43) ALDH1A1CA12CA9CASP3MEN1
SCHEMBL28110900 0.74 CASP3 (0.43) ALDH1A1CASP3MEN1KMT2ACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114158-A1 3-SUBSTITUTED-[1,2,3]BENZOTRIAZINONE COMPOUNDS FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES CORTEX PHARMACEUTICALS, INC. (US) 2009-11-11 EP disclosed
WO-2008085505-A1 3-SUBSTITUTED-[1,2,3]BENZOTRIAZINONE COMPOUNDS FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES CORTEX PHARMACEUTICALS, INC. (US) 2008-07-17 WO disclosed